Press Releases

Date   Headline
Apr 16, 2014 Cleveland BioLabs Announces the Successful Completion of a Phase 1 Study of CBL0102
Apr 01, 2014 CBL0137 Combination Studies to Be Presented at 2014 AACR Annual Meeting
Mar 11, 2014 Cleveland BioLabs Reports Fourth Quarter and Fiscal 2013 Financial Results and Development Progress
Mar 10, 2014 Cleveland BioLabs to Host Fourth Quarter Earnings Webcast Live on Tuesday, March 11, 2014
Feb 27, 2014 Cleveland BioLabs to Report Fourth Quarter and Fiscal 2013 Financial Results and Provide Operational Update on March 11
Feb 04, 2014 Cleveland BioLabs to Present at 2014 BIO CEO & Investor Conference
Jan 23, 2014 Cleveland BioLabs Provides Update on Barda Development Proposal
Jan 14, 2014 Cleveland BioLabs Announces $7 Million At-The-Market Registered Direct Offering
Dec 18, 2013 Cleveland BioLabs Announces Departure of Jean Viallet to Assume Oncology Development Leadership Role at Leading Biopharmaceutical Company
Dec 03, 2013 Cleveland BioLabs to Present at Oppenheimer 24th Annual Healthcare Conference
Nov 21, 2013 Cleveland BioLabs and Incuron Announce Poster Presentation at Society of Neuro-Oncology Meeting
Nov 06, 2013 Cleveland BioLabs Reports Third Quarter 2013 Financial Results and Development Progress
Oct 29, 2013 Cleveland BioLabs to Report Third Quarter 2013 Financial Results and Provide Operational Update on November 6
Oct 23, 2013 Panacela Signs Contract for Approximately $4.6 Million With Russian Ministry of Industry and Trade for Development of Mobilan; Announces Appointment of Michael Fonstein as CEO and President
Oct 18, 2013 Cleveland BioLabs Optimizes Operational Focus on Clinical Development
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue